tiprankstipranks
Adaptive Biotechnologies Corp (ADPT)
NASDAQ:ADPT
US Market

Adaptive Biotechnologies (ADPT) Income Statement

Compare
897 Followers

Adaptive Biotechnologies Income Statement

Last quarter (Q4 2024), Adaptive Biotechnologies's total revenue was $47.46M, an increase of 3.66% from the same quarter last year. In Q4, Adaptive Biotechnologies's net income was $-33.69M. See Adaptive Biotechnologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 178.96M$ 170.28M$ 185.31M$ 154.34M$ 98.38M
Gross Profit
$ 106.88M$ 94.72M$ 127.40M$ 105.04M$ 75.85M
Operating Expenses
$ 269.43M$ 321.76M$ 327.58M$ 314.01M$ 228.67M
Depreciation and Amortization
$ 19.26M$ 22.23M$ 28.15M$ 20.98M$ 11.74M
EBITDA
$ -128.76M$ -189.27M$ -167.98M$ -193.34M$ -144.34M
Operating Income
$ -162.55M$ -227.03M$ -200.19M$ -208.97M$ -152.82M
Other Income/Expenses
$ 3.06M$ 1.73M$ -182.00K$ 1.67M$ 6.59M
Pretax Income
$ -159.49M$ -225.30M$ -200.37M$ -207.30M$ -146.23M
Net Income
$ -159.49M$ -225.25M$ -142.46M$ -205.61M$ -139.64M
Per Share Metrics
Basic EPS
$ -1.08$ -1.56$ -1.00$ -1.46$ -1.06
Diluted EPS
$ -1.08$ -1.56$ -1.00$ -1.46$ -1.06
Weighted Average Shares Outstanding
147.10M 144.38M 142.52M 140.35M 131.22M
Weighted Average Shares Outstanding (Diluted)
147.10M 144.38M 142.52M 140.35M 131.22M
Currency in USD

Adaptive Biotechnologies Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis